Status:
COMPLETED
Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia
Lead Sponsor:
Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
Conditions:
Dyslipidemias
Children, Only
Eligibility:
All Genders
7-16 years
Phase:
NA
Brief Summary
Data concerning the effectiveness od nutraceuticals in children with dyslipidemia are lacking. The aim of the present study was to evaluate the efficacy and safety of the long-term use of a dietary su...
Detailed Description
This is a prospective single center cohort study conducted at Outpatient Lipid Unit of 2nd Department of Pediatrics of the National and Kapodistrian University of Athens at the "Panagiotis \& Aglaia K...
Eligibility Criteria
Inclusion
- LDL-C \>150 mg/dl in more than two measurements, after therapeutic lifestyle changes for at least 6 months.
Exclusion
- Secondary hypercholesterolemia
- Presence of any chronic disease or growth and developmental disorders
- Abnormal liver, kidney or thyroid function
- Prior use of hypolipidemic or other medication, at least 6 months before participation in the study.
Key Trial Info
Start Date :
January 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 5 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06045377
Start Date
January 20 2020
End Date
September 5 2022
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lipid Outpatient Unit, 2nd Department of Pediatrics, Medical School, National and Kapodistrian University of Athens (NKUA), "P. & A. Kyriakou" Children's Hospital
Athens, Greece